Timothy Miller, M.D., Ph.D. is a professor of Neurology at Washington University in St. Louis where he directs the Miller Lab and co-directs the ALS Center. His group focuses on developing novel therapies for neurodegenerative diseases, including ALS and tauopathies. Dr. Miller has pioneered work with antisense oligonucleotides (ASOs) and has led ASO clinical trials in SOD1-related ALS. He recently served as co-chair of the Northeast ALS (NEALS) Consortium and has received several prestigious awards for his ALS research.